Missouri Clinical Trials

Recruiting studies in Missouri

• Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
  NCT06095583PHASE3Shanghai Junshi Bioscience Co., Ltd.Limited-stage Small Cell Lung Cancer (LS-SCLC)St Louis, MO
• Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
  NCT07708727PHASE2, PHASE3Gilead SciencesHIV-1-infectionKansas City, MO
• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
  NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerSt Louis, MO
• A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
  NCT07525206PHASE3AbbVieColorectal CancerKansas City, MO
• Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
  NCT04924075PHASE2Merck Sharp & Dohme LLCPheochromocytoma/ParagangliomaSt Louis, MO
• A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
  NCT07088068PHASE3SanofiType 1 Diabetes MellitusKansas City, MO
• A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
  NCT05947851PHASE3Merck Sharp & Dohme LLCLeukemia, Lymphocytic, Chronic, B-CellKansas City, MO
• Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial
  NCT07220187PHASE3SWOG Cancer Research NetworkRichter SyndromeCity of Saint Peters, MO
• Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
  NCT07661056PHASE3Biohaven Therapeutics Ltd.Graves DiseaseKansas City, MO
• MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
  NCT05655312PHASE1, PHASE2Perspective TherapeuticsRecurrent Melanoma (Skin)St Louis, MO
• A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
  NCT07630974PHASE1, PHASE2Merck Sharp & Dohme LLCMalignant NeoplasmKansas City, MO
• Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
  NCT07671911PHASE3Trevi TherapeuticsIdiopathic Pulmonary FibrosisHannibal, MO

See all 1,834 recruiting trials →

Clinical trials by Missouri metro

• St. Louis
• Kansas City

Popular conditions in Missouri

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Missouri?

Corterve aggregates actively recruiting clinical trials with sites in Missouri from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.

Are clinical trials in Missouri free to join?

Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.

What kinds of clinical trials are available in Missouri?

Missouri research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.